VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Ghosn J, Pulido F, Lopardo GD, Olczak A, Ripamonti D, Martin C, Paredes Ceballos O, Stocker H, Mendez Vazquez MJ, Gatanaga H, Metallidis S, Elbirt D, Whitlock G, Mateo González JI, Mohammed P, Wang K, Grove R, Wang R, Jewell A, Sutton K, Elliot E, Moodley R, Borsi R, Jones B, Kisare M, Budnik P, van Wyk J, VOGUE Study Group, VOGUE Study Group

Open source

DOI: 10.1093/ofid/ofag471
Published: 2026 Aug
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag471,
  title = {VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.},
  author = {Ghosn J and Pulido F and Lopardo GD and Olczak A and Ripamonti D and Martin C and Paredes Ceballos O and Stocker H and Mendez Vazquez MJ and Gatanaga H and Metallidis S and Elbirt D and Whitlock G and Mateo González JI and Mohammed P and Wang K and Grove R and Wang R and Jewell A and Sutton K and Elliot E and Moodley R and Borsi R and Jones B and Kisare M and Budnik P and van Wyk J and VOGUE Study Group and VOGUE Study Group},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag471},
  url = {https://doi.org/10.1093/ofid/ofag471}
}

RIS

TY  - JOUR
TI  - VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.
AU  - Ghosn J
AU  - Pulido F
AU  - Lopardo GD
AU  - Olczak A
AU  - Ripamonti D
AU  - Martin C
AU  - Paredes Ceballos O
AU  - Stocker H
AU  - Mendez Vazquez MJ
AU  - Gatanaga H
AU  - Metallidis S
AU  - Elbirt D
AU  - Whitlock G
AU  - Mateo González JI
AU  - Mohammed P
AU  - Wang K
AU  - Grove R
AU  - Wang R
AU  - Jewell A
AU  - Sutton K
AU  - Elliot E
AU  - Moodley R
AU  - Borsi R
AU  - Jones B
AU  - Kisare M
AU  - Budnik P
AU  - van Wyk J
AU  - VOGUE Study Group
AU  - VOGUE Study Group
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag471
UR  - https://doi.org/10.1093/ofid/ofag471
ER  -

APA

J, G., F, P., GD, L., A, O., D, R., C, M., O, P. C., H, S., MJ, M. V., H, G., S, M., D, E., G, W., JI, M. G., P, M., K, W., R, G., R, W., A, J., K, S., E, E., R, M., R, B., B, J., M, K., P, B., J, V. W., Group, V. S., & Group, V. S. (2026). VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag471

Source records

pubmed · retrieved 2026-09-26T23:26:41.559Z